Rationale: Sex hormones have effects on the left ventricle, but hormonal influences on the right ventricle (RV) are unknown. Objectives: We hypothesized that sex hormones would be associated with RV morphology in a large cohort free of cardiovascular disease. Methods: Sex hormones were measured by immunoassay and RV ejection fraction (RVEF), stroke volume (RVSV), mass, end-diastolic volume, and end-systolic volume (RVESV) were measured by cardiac magnetic resonance imaging in 1,957 men and 1,738 postmenopausal women. The relationship between each hormone and RV parameter was assessed by multivariate linear regression. Conclusions: Higher estradiol levels were associated with better RV systolic function in women using hormone therapy. Higher levels of androgens were associated with greater RV mass and volumes in both sexes.Keywords: sex; sex hormones; right ventricle Sex differences in atherosclerosis and congestive heart failure (CHF) have been well described, with women experiencing a significant lag in the onset of coronary artery disease and lower rates of CHF compared with men (1). Estrogen, testosterone, dehydroepiandrosterone (DHEA), and sex hormone-binding globulin (SHBG) have important, albeit controversial, roles in left ventricular (LV) function and systemic vascular disease, whereas the effects of sex hormones on right ventricular (RV) and pulmonary vascular function are unknown.Estrogen has protective effects on the pulmonary vasculature and improves RV contractility in animals (2-4). Testosterone has been shown to be a pulmonary vasodilator, yet has unclear effects on pulmonary endothelium (5, 6). Treatment with DHEA prevents pulmonary vascular changes and RV hypertrophy, and prolongs survival in animal models of pulmonary hypertension (PH) (7,8). SHBG is expressed in myocytes of failing human hearts and in murine fetal lung epithelium, but its role in pulmonary vascular function has not been studied (9, 10).Despite the beneficial effects of estrogen on the pulmonary vasculature, female sex is the best established clinical risk factor for idiopathic pulmonary arterial hypertension (PAH) (11). Yet, women have higher RV ejection fraction (RVEF) and improved survival compared with men with PAH (12-14). In systemic cardiovascular disease, an individual's estrogen:testosterone balance may be more predictive of disease risk than either hormone alone (15,16). Last, it is unknown how sex hormones affect the interaction of the RV with the pulmonary vasculature, particularly in individuals with no known (or subclinical) PH.We examined the cross-sectional association of serum estradiol (E2), bioavailable testosterone (bioT), DHEA, SHBG, and the E2:testosterone ratio (E2:T) with RV structure and function assessed by cardiac magnetic resonance imaging (MRI) in a large
AT A GLANCE COMMENTARY Scientific Knowledge on the SubjectFemale sex is a risk factor for the development of pulmonary hypertension (PH), yet women appear to have better right ventricular (RV) function and improved survival compared to men with PH....